FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefoxitin for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/03/2019
»Therapeutic Categories: Anti-Infective

Expand all

Apotex Corp. (Reverified 10/28/2020)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (25 vials) (NDC 60505-0759-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
2 g (25 vials) (NDC 60505-0760-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
10 g (10 vials) (NDC 60505-0761-04) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug

B. Braun Medical Inc. (Revised 09/08/2020)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11) Available Other
Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11) Available Other

Fresenius Kabi USA, LLC (Revised 10/23/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g per vial; SDV; (NDC 63323-341-25) Backordered. Next release November 2020. Check wholesalers for inventory Manufacturing delays
2 grams per vial; SDV; (NDC 63323-342-25) Backordered. Next release November 2020. Check wholesalers for inventory Manufacturing delays

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 07/22/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1g vial (NDC 0143-9878-25) Inventory is currently available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
2g vial (NDC 0143-9877-25) Inventory is currently available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
10g vial (NDC 0143-9876-10) Inventory is currently available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug

Sagent Pharmaceuticals (Revised 10/22/2020)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 g, package of 10 vials (NDC 25021-111-99) Available
1 g, package of 10 vials (NDC 25021-109-10) On backorder. Estimated availability Dec 2020 Manufacturing delay
2 g, package of 10 vials (NDC 25021-110-20) On allocation. Estimated availability Nov 2020 Manufacturing delay

WG Critical Care (Reverified 10/05/2020)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (NDC 44567-245-25) Available Please check wholesalers for available inventory. Demand increase for the drug
2 g (NDC 44567-246-25) Available Please check wholesalers for available inventory. Demand increase for the drug
10 g (NDC 44567-247-10) Available Please check wholesalers for available inventory. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English